← Leaderboards
Lucas Ferrari De Andrade
Icahn School Of Medicine At Mount Sinai
$1,481,935
Attributed
$1,481,935
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $520.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,481,935 · 1
By mechanism
R37$1,481,935 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Saghi Ghaffari$11,733,780
- Kalung Cheung$3,083,531
- Amir Horowitz$1,902,078
- John Sfakianos$1,435,953
- Andrew Chow$685,068
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAcute Myeloid Leukemia CellAffinityAnalogAntibodiesAntigensAntileukemic ActivityBindingBiologyBloodBone MarrowBypassCancer CellCancer TypeCd34 GeneCell LineCellsCellular ImmunityCellular StressClinical TrialsCollaborationsCytotoxicCytotoxic T-LymphocytesAcademia
Grant awards (3)
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding$520,895
R37 · FY2025 · CA · contact PI
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding$468,199
R37 · FY2024 · CA · contact PI
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding$492,841
R37 · FY2023 · CA · contact PI